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DREAM/calsenilin/KChIP3 is a calcium binding protein of the neuronal calcium sensor superfamily. DREAM interacts with 
DRE (downstream regulatory element) sites in the DNA to regulate transcription and with many proteins to exert specialized 
functions in different subcellular compartments. Work from different laboratories has identified a growing list of interacting 
proteins that constitutes the DREAM interactome. The knowledge of these interactions has greatly contributed to the under-
standing of the various physiological functions of DREAM. 
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1  DREAM, a multifunctional protein 
DREAM (Antagonist Modulator of DRE sites) was cloned 
in a functional screening of a cDNA library from human 
striatum as a transcriptional repressor able to form tetramers 
and bind to the DRE site in the proximal promoter of the 
human prodynorphin gene [1,2]. DREAM is expressed in 
brain, thyroid gland, immune system, heart and gonads and 
is one of four highly conserved members of the KChIP (po-
tassium channel interacting protein) subfamily of neuronal 
calcium sensors [3,4]. 
DREAM, also known as calsenilin [5] or KChIP3 [3], is 
a calcium binding protein that contains three functional 
EF-hand motifs (Figure 1) and interacts with DRE (down-
stream regulatory element) sites in the DNA and with many 
proteins to exert specialized functions in different sub-         
cellular compartments [6]. Binding of calcium induces a 
structural change in DREAM that precludes binding to 
DNA and modifies the interaction with some proteins but 
not with others. For instance, Ca2+-bound DREAM does not 
interact with CREB [7] or with the PSD-95 protein [8], 
while the interaction of DREAM with presenilins [5], with 
potassium channels of the Kv4 class [3] or with the TSH 
receptor [9], is not affected by calcium. 
A key property of DREAM is the ability to form homo-
mers or heterotetramers with other KChIP proteins, which 
results in different affinities for DNA binding to DRE sites 
proximal to the transcription start site, leading to transcrip-
tional repression of target genes [2,4,10,11]. The DRE se-
quence was defined as the element responsible for basal and 
induced expression of the prodynorphin gene, encoding a 
protein involved in nociception as well as in learning and 
memory [12,13]. More recent studies, however, have shown 
that many other genes also contain DRE sites and are regu-
lated by DREAM. For instance, DRE sites contribute to 
basal and induced expression of a number of immediate 
early transcription factors including c-fos, c-jun and ICER 
[2,4]. In addition to its regulation by calcium, binding of 
DREAM to DNA is hampered by its interaction with phos-
phoCREM [14], while interaction with other transcription  
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Figure 1  The DREAM protein and alignment with other KChIPs. A, Schematic representation of the DREAM protein showing the LCD and EF-hand 
motifs. B, Sequence alignment of DREAM and KChIP family members. The human sequences for DREAM (Acc. Q9Y2W7), KChIP 1 (Q9NZI2), KChIP 2 
(Q9NS61) and KChIP 4 (Q6PIL6) were aligned. Asterisk (*) denotes identical residues, colon (:) conservative changes and period (·) related substitutions. 
Sumoylation sites are boxed showing the sumoylated lysine in red. EF-hand motifs are also boxed, the three functional hands depicted in blue. LCD motifs  
and other amino acids important for function such as cysteins at positions 45 and 46, and the phosphorylation site at serine 95, are shown in red. 
factors like CREB, TTF-1 or CtBP2 allows DREAM to 
regulate transcription of genes that do not contain DRE sites 
(Figure 2) [7,15,16]. Outside the nucleus, DREAM regu-
lates many cellular functions through selective interactions 
with an increasing number of proteins that constitute the 
DREAM interactome and underscore DREAM multifunc-
tional properties. 
2  Defining the DREAM interactome 
DREAM plays an important role in cell physiology through 
the interaction with specific proteins in different subcellular 
compartments and in various cell types. In fact, and inde-
pendently to its discovery as a calcium-regulated repressor, 
DREAM/calsenilin was identified based on its interaction 
with the C-terminal fragment of presenilin-2 in a yeast 
two-hybrid assay [5]. The interaction was found to be in-
sensitive to Ca2+, and as a result, DREAM was proposed to 
enhance presenilin-induced calcium release from the ER to 
the cytosol [17] and may control γ-secretase activity and Aβ 
aggregation in neurons [18]. The role of DREAM/calsenilin 
in the processing of the amyloid precursor protein, however, 
remains controversial and different groups have published 
ambiguous results, including reduced levels of Aβ peptides 
in DREAM/calsenilin knock-out mice [18], increased level 
of DREAM/calsenilin in AD (Alzheimer’s disease) brains 
[19] and in neuronal cultures after exposure to Aβ42 [20] or 
unchanged level in a transgenic mouse model of AD [21]. 
Also applying the yeast two-hybrid approach, other 
Ca2+-independent interactions have been described. Using 
the N-terminal region of the Kv4 potassium channel as bait, 
three of the four members of the KChIP family, of which 
DREAM is KChIP3, were found [3]. Binding of DREAM/ 
KChIP3 to the Kv4 channel occurs in the endoplasmic re-
ticulum and, upon binding, DREAM facilitates intracellular 
trafficking and membrane expression of the channel [3]. In 
addition, DREAM regulates the gating of the Kv4 channel 
in the membrane, slowing inactivation and accelerating the 
recovery to the functional state. Interestingly, although the 
binding is insensitive to Ca2+, regulation of the gating needs 
the integrity of the EF-hands in the DREAM protein [3]. In 
another yeast two-hybrid assay, using the N-terminal of 
DREAM as bait the interactions with the transcriptional 
corepressor C-terminal binding protein 2 (CtBP2) and its 
homolog CtBP1 were identified [16]. Interestingly, histone 
deacetylase (HDAC) protein and activity was found to be 
associated with the DREAM-CtBP immunocomplex, sug- 
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Figure 2  Schematic models of the DRE-dependent and DRE-indepen-     
dent modulation of the transcriptional activity of DREAM. A, Binding of 
DREAM to DRE sites is modulated by the interaction with phosphoCREM, 
which releases DREAM from the DNA preventing DREAM-mediated 
transcriptional repression. B, DREAM binds to CREB and prevents the 
interaction between CREB and its coactivator CBP, thus blocking 
CREB-mediated transcriptional activity. C, DREAM forms transcriptional 
regulatory complexes through its binding to other transcription factors  
(TTF-1), corepressors (CtBP) and HDACs. 
gesting a mechanism by which DREAM-CtBP may act to 
repress transcription. Surprisingly, the DREAM-CtBP in-
teraction was also detected in synaptic vesicles, suggesting 
that outside the nucleus the DREAM-CtBP interaction may 
play a role in the maintenance, release or trafficking of the-
se vesicles [16]. Also the Ca2+-independent interaction of 
DREAM and KChIP-4 with the galactosyltransferase GalT2 
was detected by yeast two-hybrid screening using the 
N-terminal domain of GalT2 as bait [22]. GalT2 is a Golgi-      
resident type II membrane protein that participates in the 
synthesis of glycosphingolipids. Cotransfection experiments 
showed that DREAM and GalT2 mutually affect their sub-
cellular distribution. Thus, in the presence of GalT2 the 
diffuse distribution of DREAM partially changes, showing a 
tendency to form clustered structures in the perinuclear re-
gion. Interestingly, GalT2 also affects DREAM stability, 
accelerating its proteolysis by the proteosome. Conversely, 
DREAM leads to redistribution of GalT2, as well as two 
other galactosyltransferases (SialT2 and GalNAcT), from 
the Golgi to the ER. These data suggested that DREAM 
might be involved in the trafficking of Golgi glycosyltrans-
ferases [22]. 
3  The LCD-dependent interactome 
Characterization of the DREAM interactome was initially 
based on results from the yeast two-hybrid assays men-
tioned above and on data from functional analyses of 
DREAM. Three examples illustrate this second source of 
information, the interactions with CREM, CREB and the 
vitamin D receptor. The interaction with CREM was dis-
covered during studies on the regulation of DREAM DNA 
binding by cAMP [1,14]. These characterized the high-        
affinity interaction between phosphoCREM and DREAM, 
which was found to be mediated by two leucine-, charged 
residue-rich domains (LCDs) in the DREAM protein, here-
after named LCD1 and LCD2 (Figure 1). Two LCDs in 
CREM, one in the N-terminal domain and one in the bZIP 
region in the C-terminal domain, are also needed. The in-
teraction is facilitated by the cAMP-dependent phosphory-
lation of CREM at serine 68, in turn blocking binding of 
DREAM to the DRE site in the target gene prodynorphin 
and leading to derepression of its expression [14]. Based on 
the high sequence homology between CREM and CREB, 
the role of a putative LCD in CREB was investigated and, 
in fact, this was found to be equivalent to the CREM 
C-terminal LCD. Importantly, this LCD is located in the 
KID domain of CREB, which mediates interaction with 
CBP/p300 allowing HAT recruitment and transactivation of 
CRE sites [23]. The interaction involves LCD1 in DREAM 
and is Ca2+-dependent. Consequently, Ca2+-insensitive 
DREAM mutants permanently occupy the KID domain, 
blocking the CREB-CBP interaction and CRE-dependent 
gene expression [7]. 
LCD domains were originally identified as responsible for 
the interaction between hormone nuclear receptors and the 
transcriptional machinery [24]. Thus, we searched for an 
LCD-based functional interaction between DREAM and nu-
clear receptor-dependent transcription. We disclosed that 
DREAM enhances basal and ligand-dependent activation of 
promoters containing vitamin D and retinoic acid response 
elements (VDREs and RAREs). The promoter activation 
requires both LCDs in DREAM and is enhanced in the pres-
ence of Ca2+ [25]. Chromatin immunoprecipitation using 
vitamin D- or retinoic acid-treated cells demonstrated the 
presence of DREAM in nuclear complexes bound to regula-
tory regions containing VDRE and RAREs [25] and 
pull-down assay has confirmed the direct interaction between 
DREAM and vitamin D receptors [26]. Taken together, these 
interactions show that, in the presence of Ca2+, DREAM can 
function as a transcriptional activator of promoters containing 
CRE sites or binding sites for nuclear receptors. 
4  The thyroid-specific DREAM interactome 
Analysis of the functional role of DREAM in the thyroid 
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gland showed that DREAM interacts with the N-terminal 
region of TTF-1 and impairs the transcriptional activity of 
its main transactivating domain to downregulate thy-
roglobulin gene expression [15]. Chromatin immunoprecip-
itation experiments showed that DREAM binds to the thy-
roglobulin promoter and promoter deletion analysis identi-
fied the binding of DREAM to a region overlapping the 
binding site for TTF-1 and Pax-8 in the thyroglobulin pro-
moter. These results support the idea that DREAM may 
form transcriptional regulatory complexes with other part-
ners on the promoters of their target genes [15]. Interest-
ingly, the interaction between DREAM and TTF-1 does not 
involve the LCD domains of DREAM. 
Furthermore, working with thyroid follicular cells, we 
found that DREAM interacts with the C-terminal intracellular 
part of TSHR regulating its membrane expression and pro-
moting its binding to the Gα subunit. As a result, DREAM 
over-expression led to enhanced activation of TSHR activity 
with increased induction of the cAMP signalling cascade [9]. 
Modulation of TSHR protein levels and increased receptor 
activity were achieved through independent mechanisms. 
Thus, a DREAM-derived peptide containing amino acids 
43–62 was able to activate the receptor without affecting its 
protein level. Accordingly, membrane stabilization of 
TSHR by the Ca2+-binding chaperone calreticulin did not 
induce the cAMP cascade. Importantly, interaction with 
THSR requires the N-terminal region, amino acids 1-90, of 
DREAM, which is not present in the other members of the 
KChIP family. Thus, the effect of DREAM on TSHR is not 
reproduced by KChIP-2, which is also expressed in the thy-
roid gland [9,15]. Therefore, despite the great sequence 
homology and redundancy in some activities among the 
different KChIP proteins [3,4], the N-terminal part deter-
mines specific functions for DREAM. 
5  Ca2+-dependent interactions revealed by 
yeast two-hybrid 
The interactions found as a result of functional studies 
turned out in most of the cases to be Ca2+-dependent, while 
those discovered using the yeast two-hybrid assay were not 
sensitive to calcium. In this situation, it was reasonable to 
think that perhaps the high calcium concentration in yeast 
cytosol precluded the calcium-sensitive interactions be-
tween DREAM and bait proteins. To overcome this poten-
tial technical bias, we designed a yeast two-hybrid assay 
using as bait a Ca2+-insensitive DREAM mutant, with muta-
tions in each one of the three functional EF-hands. Results 
from this screening confirmed the hypothesis and allowed 
us to describe several new interactions that were in all cases 
sensitive to the presence of calcium. Three of these interac-
tions, namely with GRK, Ubc9 and Prdx3, have been re-
cently characterized at the molecular level, providing new 
insights in the functionality of the DREAM protein. 
Since the interactions between G-coupled receptor ki-
nases (GRK) and several other neuronal calcium sensors 
had been already reported [27], the interaction between 
DREAM and GRK6 and GRK2 kinases observed was 
somehow a predictable result [28]. We found that the inter-
action with GRK6 and GRK2 results in the phosphorylation 
of DREAM at Ser95. The phosphorylation does not modify 
the repressor activity of DREAM, but dramatically influ-
ences the trafficking of Kv4 potassium channels from the 
ER to the cell membrane [28]. Thus, mutation of Ser95 to 
aspartic acid blocked DREAM-mediated membrane expres-
sion of Kv4.2 potassium channels without affecting channel 
tetramerization. Furthermore, treatment with the calcineurin 
inhibitors, FK506 and cyclosporin A, also blocked 
DREAM-mediated Kv4.2 channel trafficking suggesting 
that calcineurin participates in the dephosphorylation of 
Ser95 phosphoDREAM. Thus, both phosphorylation and 
dephosphorylation of DREAM at Ser95 are tightly regulat-
ed in a Ca2+-dependent manner and so is the activity of 
DREAM on Kv4.2 channel function [28]. 
The interaction with the SUMO-conjugating enzyme 
Ubc9 led to the identification of DREAM as a target for 
sumoylation. Single K-to-R mutations at positions K26 and 
K90 prevent in vitro sumoylation of recombinant DREAM 
and reduce nuclear localization of DREAM [29]. These re-
sults suggested that sumoylation regulates the nuclear locali-
zation of DREAM and thereby determines its transcriptional 
repressor activity. Indeed, it was shown that in PC12 cells, 
sumoylated DREAM is present exclusively in the nucleus, 
and accordingly, in fully differentiated trigeminal neurons, 
DREAM and SUMO-1 colocalize in nuclear domains asso-
ciated with transcription [29]. Sequence analysis of the four 
members of the KChIP family (Figure 1) shows that the 
sumoylation consensus site K26, located in the 
DREAM-specific N-terminal region, is not present in the 
other three members, while the sumoylation site at K90 is 
conserved in KChIP 1 and 2 but not in KChIP4. Thus, 
sumoylation of other KChIP family members may occur but 
is presently unknown. Whether sumoylation alters the in-
teraction of DREAM with other nucleoproteins and whether 
DREAM affinity or specificity for DRE sites is affected by 
sumoylation remains to be analyzed. 
Third, the yeast two-hybrid assay with mutant DREAM 
as bait disclosed the interaction with peroxiredoxin 3 
(Prdx3), an antioxidant enzyme of the thioredoxin system 
that protects neurons from oxidative damage [30]. The 
DREAM-Prdx3 interaction is greatly reduced in the pres-
ence of calcium and is blocked in the presence of DTT, 
suggesting that DREAM preferentially interacts with Prdx3 
under oxidizing conditions. The interaction is specific for 
Prdx3 and was not observed for other members of the Prdx 
family, such as the nuclear localized Prdx5. The functional 
relevance of this interaction is intriguing, since Prdx3 is a 
mitochondrial protein, not located in the cytosol or in the 
nucleus, while mitochondrial localization for DREAM has 
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so far not been reported. Therefore, whether this interaction 
takes place within the mitochondria or in the cytosol fol-
lowing the release of mitochondrial factors during oxidative 
stress remains an open question. The DREAM-Prdx3 inter-
action led us to demonstrate that DREAM plays a neuro-
protective role in response to oxidative stress. Moreover, it 
served to disclose that both DNA-binding and oligomeriza-
tion activity of DREAM are modulated by the redox state of 
two cysteine residues located at positions 45 and 46. Muta-
tion of Cys to Ser in the DREAM-C45,46S mutant was used 
to investigate the influence of the redox state on DREAM 
activity. Cys to Ser mutations mimic a permanent reduced 
form of cysteins and prevent the formation of either intra- or 
intermolecular disulfide bonds. As a result, the DREAM-    
C45,46S mutant showed greater dimer formation capacity 
and stronger repressor effect on DRE-dependent transcrip-
tion [30]. Since these two residues are immediately preced-
ing LCD1, it is likely that their redox state may also affect 
the interaction with other DREAM partners such as CREM 
or CREB. Moreover, KChIP2 also contains double Cys res-
idues in equivalent positions, while KChIP1 and 4 contains 
a single Cys residue (Figure 1). This suggests that redox 
signaling might favor the formation of specific 
DREAM/KChIP homo- and hetero-oligomers to elicit spe-
cific functions. 
6  Recent additions to the membrane-specific 
DREAM interactome 
In addition to the mentioned interactions of DREAM with 
Kv4 channels and TSHR, several recent studies are uncov-
ering novel interactions that point to an expanded role of 
KChIP proteins in the regulation of membrane-bound pro-
teins. While studying the reduction of NMDA-mediated 
currents in transgenic neurons expressing a Ca2+-insensitive 
DREAM mutant, we identified the Ca2+-dependent interac-
tion with PSD-95 [8]. We proposed that this interaction 
could compete the PSD-95/src interaction, in turn precluding 
NR2B Tyr-phosphorylation and NMDA receptor full activity 
[8]. Interestingly, an independent study confirmed the reduc-
tion of NMDA-mediated currents by DREAM, though in this 
case the mechanism involved a Ca2+-dependent interaction 
between the N-terminal region of DREAM and the NR1 
subunit of the NMDA receptor [31]. Moreover, it was 
shown that wild-type DREAM and DREAM N-terminal 
peptides negatively regulate NMDA currents and reduce 
NMDA-induced cytotoxicity [31]. Together, these studies 
propose that DREAM impinges on NMDA-mediated cur-
rents at multiple levels. Since the N-terminal residues 1–50 
of DREAM are not conserved in the other KChIP proteins, 
these results also indicate that the interaction and modula-
tion of the NMDA receptor is DREAM specific and not 
shared by other KChIPs. 
Two recent reports further implicate DREAM in regula-
tion of membrane conductance. One report demonstrates 
that DREAM forms a signaling complex with Kv4 and 
voltage-dependent T-type calcium channels (Cav3) in stel-
late cells [32]. Electrophysiological measurements propose 
that T-type channels efficiently couple calcium influx to 
DREAM/KChIP3 to modulate Kv4 function, establishing 
DREAM as a physiological calcium sensor for the Kv4 
channel in neurons. A second work using KChIP2−/− cardiac 
myocytes has shown that KChIP2 directly interacts with 
voltage-dependent L-type calcium channels (Cav1.2) aug-
menting their current amplitude [33]. Whether other 
KChIPs can also interact with Ca2+ channels and the physi-
ological significance in different tissues remains to be in-
vestigated. Nevertheless, these reports collectively point to 
DREAM and other KChIP proteins as key modulators of 
membrane conductance through the interaction with multi-
ple cationic channels. 
7  New approaches to uncover the DREAM in-
teractome 
With the exception of the interaction with the transcriptional 
corepressor CtBP2, all positive interactions in yeast two-       
hybrid assays correspond to cytosolic or membrane-bound 
proteins. This may be due to a low representation of nucle-
oprotein-encoding clones in yeast libraries or, alternatively, 
it may be related to the complexity of these interactions, 
which are not favored in the yeast environment. For in-
stance, although the interactions of CREM or CREB with 
DREAM are strong and reliable, no yeast clones encoding 
CREM or CREB were obtained. Of note, these interactions 
were also absent in a recent high-throughput yeast two-hy-       
brid screening aiming to a systematic mapping of protein-     
protein interactions, despite DREAM ORFs being repre-
sented in the employed library [34]. To overcome these po-
tential technical drawbacks, other methodological ap-
proaches could be attractive alternatives, including affinity 
pull-down techniques, high-density protein microarrays and 
stable isotopic labeling coupled to immunoprecipitation, 
liquid chromatography and mass spectrometry analysis. 
A representative example of one of these approaches is 
the search for direct protein-protein interactions between 
Taiwan cobra cardiotoxin3 (CTX3) and KChIPs, using 
affinity pull-down assays and chemical cross-linking [35]. 
Cardio toxins (Cuts) form a group of polypeptides present 
in the elapid family of snakes. They are known to have 
Ca2+-dependent cellular effects and a diversity of pharma-
cological functions, including hemolysis, cytotoxicity, and 
depolarization of muscles. All KChIPs interact with CTX3 
albeit detailed characterization of the interaction was carried 
out only for KChIP-1. Binding of CTX3 to KChIP1 re-
quired the integrity of EF-hands 3 and 4 of KChIP1, alt-
hough the interaction was found to be Ca2+-independent. 
KChIP-1 was able to interact simultaneously with CTX3  
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Table 1  DREAM interacting proteins 
Gene Ca2+ Compartment Function References 
CREM + nucleus transactivation Ledo [14] 
CREB + nucleus transactivation Ledo [7] 
presenilin − cytosol ER Ca2+ release Buxbaum [5] 
TTF-1 − nucleus transactivation Rivas [15] 
Kv4 − ER trafficking/gating An [3] 
TSHR − membrane receptor modulation Rivas [9] 
GRK + cytosol trafficking Ruiz-Gomez [28] 
Ubc9 + cytosol nuclear translocation Palczewska [29] 
Prdx3 + n.d.a) n.d. Rivas [30] 
PSD95 + cytosol NMDAR activity Wu [8] 
Cav T-type + membrane receptor modulation Anderson [32] 
Cav L-type + membrane receptor modulation Thomsen [33] 
GalT2 − Golgi trafficking/proteolysis Quintero [22] 
CtBP − synaptic vesicles transactivation Zaidi [16] 
CTX3 − membrane Kv modulation Lin [35] 
NMDR1 + membrane current regulation Zhang [31] 
a) n.d. = not determined. 
 
 
and the N-terminal fragment of the Kv4.2 channel. Interest-
ingly, the interaction between KChIP-1 and the channel was 
enhanced in the presence of CTX3, which suggests that 
CTX3 might regulate the electrophysiological properties of 
Kv channels. Given the high sequence homology and func-
tional redundancy of the KChIP proteins in terms of the 
regulation of Kv4 channels, we speculate that KChIP3/     
DREAM would behave similarly. 
8  Conclusion 
The list of DREAM interacting proteins (Table 1) has 
grown considerably in the last few years. The present in-
ventory, far from complete, awaits exciting additions that, 
for instance, should complete the nuclear DREAM interac-
tome by identifying elements of the basic transcriptional 
machinery that interact with DREAM and define its tran-
scriptional repressor activity. New interactions should also 
be expected at the cell membrane. One reason for this is that 
DREAM might share in part the interactome of other neu-
ronal calcium sensors [36], as shown for GRKs, and if so, 
many interactions of specific functional significance could 
be disclosed. Moreover, future studies of the enhanced cou-
pling between TSHR and G proteins upon DREAM binding 
to the receptor may identify new interactions mediating 
changes in signaling, receptor trafficking and receptor stabi-
lization. Taken together, the growing DREAM interactome 
highlights the diverse roles of DREAM as a multifunctional 
protein with specific roles in different cell compartments. 
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